醫(yī)療機(jī)構(gòu)在優(yōu)化院內(nèi)藥品結(jié)構(gòu)、合理調(diào)整藥品目錄的工作中，對(duì)待遴選藥品進(jìn)行多維度綜合評(píng)價(jià)對(duì)保障臨床基本用藥的供應(yīng)與規(guī)范使用具有重要意義。國(guó)內(nèi)在藥品遴選及評(píng)價(jià)方法方面的研究相對(duì)薄弱，與國(guó)外存在較大差距，且目前國(guó)內(nèi)現(xiàn)有的藥品遴選評(píng)價(jià)方法由于評(píng)價(jià)策略和指標(biāo)體系存在較大的差異性，給醫(yī)療機(jī)構(gòu)的選擇帶來了困惑。因此，根據(jù)國(guó)內(nèi)實(shí)際情況，制定符合醫(yī)療機(jī)構(gòu)藥品準(zhǔn)入與調(diào)出工作實(shí)際的藥品遴選評(píng)價(jià)方法至關(guān)重要。通過對(duì)國(guó)內(nèi)現(xiàn)有藥品遴選評(píng)價(jià)方法進(jìn)行分析，并結(jié)合自身工作實(shí)踐，提出構(gòu)建符合國(guó)內(nèi)醫(yī)療機(jī)構(gòu)藥品目錄動(dòng)態(tài)調(diào)整工作實(shí)際的藥品遴選評(píng)價(jià)方法的策略建議，為醫(yī)療機(jī)構(gòu)規(guī)范開展藥品遴選評(píng)價(jià)工作提供參考。

In optimizing the internal drug structure and properly adjusting the drug catalog, it is of significant importance for medical institutions to perform a multidimensional comprehensive evaluation of selected drugs to ensure the supply and proper use of essential drugs in clinical settings. Research on drug selection and evaluation methods within domestic institutions is relatively weak compared to foreign countries, and there is a significant gap. Additionally, the existing drug selection and evaluation methods in domestic institutions have caused confusion due to substantial differences in evaluation strategies and indicator systems. Therefore, it is crucial to develop drug selection and evaluation methods tailored to the actual conditions of drug access and removal in medical institutions based on the domestic situation. This paper analyzes the existing domestic drug selection and evaluation methods and proposes strategic suggestions for developing drug selection and evaluation methods that align with the practical dynamics of drug catalog adjustment in Chinese medical institutions, providing a reference for standardizing drug selection and evaluation work in medical institutions.

R97

廣東省醫(yī)學(xué)科學(xué)技術(shù)研究基金項(xiàng)目（A2023283）；廣東省醫(yī)院藥學(xué)研究基金項(xiàng)目（2024A17）；深圳市衛(wèi)生經(jīng)濟(jì)學(xué)會(huì)科研基金項(xiàng)目（202414）